Limited Coverage Drugs - Special Authority Criteria

Generic Name / Strength / Form
interferon alfa

Criteria Approval Period
Diagnosis of chronic Hepatitis B, non-cirrhosis. According to established protocols; lab work required.

Submit Hepatitis B requests using the Chronic Hepatitis B form. See form link below.

Note:   

  1. For treatment of chronic hepatitis C genotype 1, please see Limited Coverage criteria for boceprevir and boceprevir in combination with peginterferon/ribavirin
  2. For treatment of chronic hepatitis C genotype 2, 3, 4, 5 or 6, please see Limited Coverage criteria for ribavirin in combination with pegylated interferon.
1. First approval: 24 weeks

One Renewal: Up to 24 weeks, only if patient demonstrates a positive response to treatment.

Practitioner Exemptions

  • No practitioner exemptions

Special Notes

  • None

Special Authority Request Forms